Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- The Data Privacy Imperative: Safeguarding Sensitive Data
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Modern Federal Threat Landscape
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
News Summary: Pfizer disputes lawsuit over Zoloft
Thursday - 1/31/2013, 5:33pm EST
(AP) - RARE CASE: A federal lawsuit claims popular antidepressant Zoloft has no more benefit than a dummy pill, so patients who took it should be reimbursed for their costs.
OPPOSING VIEWS: Lawyer Brent Wisner says Zoloft shouldn't have been approved because there wasn't enough evidence it works. Zoloft maker Pfizer and several psychiatry experts say studies and two decades of use by patients show the pill is effective.
COMPLEX SCIENCE: It's hard to exactly measure an antidepressant's value. Most patients need to try a few to find one that works for them, and they help patients with severe depression the most.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)